Digest Network How does it work
Network
/
Society
Na
Not verified

Natera, Inc.

What we write about

BiotechnologyHealthIndustriaMedicine - variousOncology

50 Press releases

View all press releases
08/05/2025
WEB AND SOCIAL NETWORK
Phones and Miscellaneous
stock market
Health
Biotechnology
Scienza
Oncology
Natera Reports First Quarter 2025 Financial Results
Source
Natera, Inc.
Issuer
Business Wire
1.00
0
08/05/2025
Eventi
Fairs
Industria
Oncology
Health
Biotechnology
Scienza
Medicine - various
Signatera Data From I-SPY 2 Trial to Be Presented at ESMO Breast Annual Congress
Source
Natera, Inc.
Issuer
Business Wire
1.00
0
07/05/2025
Industria
Biotechnology
Health
Medicine - various
Oncology
Prospera™ Heart Test with DQS Outperforms dd-cfDNA Percentage in Detecting Allograft Rejection, New AJT Publication Shows
Source
Natera, Inc.
Issuer
Business Wire
1.00
0
05/05/2025
Industria
Scienza
Biotechnology
Medicine - various
Health
University
School / Education
Oncology
Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera
Source
Natera, Inc.
Issuer
Business Wire
1.00
0
01/05/2025
WEB AND SOCIAL NETWORK
Phones and Miscellaneous
Finance
stock market
Biotechnology
Health
Oncology
Natera to Report its First Quarter Results on May 8, 2025
Source
Natera, Inc.
Issuer
Business Wire
1.00
0
29/04/2025
Industria
Scienza
Cardiology
Biotechnology
Oncology
Health
Medicine - various
Prospective DEFINE-HT Study Demonstrates that Prospera™ Heart is Predictive of Clinical Outcomes and Outperforms Biopsy in Predicting Graft Dysfunction
Source
Natera, Inc.
Issuer
Business Wire
1.00
0
24/04/2025
Industria
Health
Sanità
Communication
Oncology
Scienza
Biotechnology
Fitness / Wellness
Windows / Shopping
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test
Source
Natera, Inc.
Issuer
Business Wire
1.00
0
22/04/2025
Oncology
Health
Biotechnology
Medicine - various
Natera To Present Data from 8 Studies at 2025 AACR Annual Meeting
Source
Natera, Inc.
Issuer
Business Wire
1.00
0
25/03/2025
Industria
Scienza
Cardiology
Biotechnology
Medicine - various
Health
DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting
Source
Natera, Inc.
Issuer
Business Wire
1.00
0
10/03/2025
Labour market
Industria
Scienza
Sanità
Biotechnology
Medicine - various
Health
Pharmaceuticals
Oncology
Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer
Source
Natera, Inc.
Issuer
Business Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0